FDA Approved: MATZIM LA — Original Application (Actavis Pharma, Inc.)

View source ↗

Summary

FDA approved MATZIM LA, a diltiazem hydrochloride extended-release tablet, under Actavis Pharma's original ANDA.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Angina Pectoris
• Atrial Fibrillation
• Atrial Flutter
• Hypertension
• Paroxysmal Supraventricular Tachycardia

Drugs mentioned

• MATZIM LA (DILTIAZEM HYDROCHLORIDE)

Snippet

ORIG AP for MATZIM LA (DILTIAZEM HYDROCHLORIDE)